Page last updated: 2024-08-21

aminoimidazole carboxamide and Dysplastic Nevus Syndrome, Hereditary

aminoimidazole carboxamide has been researched along with Dysplastic Nevus Syndrome, Hereditary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abbe, P; Amdouni, H; Auberger, P; Ben-Sahra, I; Benhida, R; Beranger, GE; Cluzeau, T; Driowya, M; Dubreuil, P; Furstoss, N; Gutierrez, VS; Jacquel, A; Jaune, E; Luciano, F; Martin, AR; O'Hara, BP; Passeron, T; Regazzetti, C; Robert, G; Rocchi, S; Tekaya, N; Tulic, MK; Zerhouni, M1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma.
    Cancer research, 2021, 07-15, Volume: 81, Issue:14

    Topics: Aged; Aminoimidazole Carboxamide; Animals; Carrier Proteins; Cell Line, Tumor; Female; HEK293 Cells; Humans; IMP Dehydrogenase; Melanoma; Melanoma, Cutaneous Malignant; Membrane Proteins; Mice; Mice, Nude; Random Allocation; Ribonucleotides; Skin Neoplasms; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Xenograft Model Antitumor Assays

2021